iBstone AuraLink vs Otofonix Groove

The iBstone AuraLink is a mid-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.6/5 in HearAdvisor's lab testing. This behind-the-ear device ranks #33 among 65 tested OTC hearing aids, placing it in the top 49% of its category. In our testing, the AuraLink shows a distinctive performance profile with notable strengths in audio entertainment. Music streaming scored a solid 3.6/5, measuring 1.68 points above the category average—a standout result for an OTC device. Feedback handling earned an excellent 5.0/5, sitting 0.46 points above average, meaning users should experience minimal whistling during daily wear. However, speech clarity presents a different picture. Speech in quiet scored a mixed 2.3/5, falling 0.47 points below the category average of 2.79. Speech in noise performance was low at 1.0/5, trailing the already modest category average by 0.48 points. Own-voice comfort scored 2.7/5, slightly above average but only mixed in absolute terms. At $649, the AuraLink faces competition from alternatives offering similar or better sound performance at lower prices, including the iHear MatriX and Olive Union Max. The AuraLink may appeal to users who prioritize music and media streaming over speech enhancement, but those seeking stronger speech clarity should explore other options in this price range.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.